Skip to main content

Cardiovascular Toxicology

Ausgabe 4/2012

Inhalt (12 Artikel)

Biological Drugs: Classic Adverse Effects and New Clinical Evidences

Paolo Della Pina, Enrico Vizzardi, Riccardo Raddino, Mara Gavazzoni, Giorgio Caretta, Elio Gorga, Livio Dei Cas

A short-term high-dose administration of sodium pivalate impairs pyruvate metabolism without affecting cardiac function

Janis Kuka, Marina Makrecka, Solveiga Grinberga, Osvalds Pugovics, Edgars Liepinsh, Maija Dambrova

Doxorubicin-induced Changes of Ventricular Repolarization Heterogeneity: Results of a Chronic Rat Study

Sergey N. Kharin, Valeria V. Krandycheva, Marina V. Strelkova, Aliona S. Tsvetkova, Dmitry N. Shmakov

The Cardioprotective Effects of an Antiemetic Drug, Tropisetron, on Cardiomyopathy Related to Doxorubicin

Houman Alimoradi, Anita Barzegar-Fallah, Gholamreza Hassanzadeh, Sanaz Mohammadi-Rick, Firouzeh Asadi, Bahram Delfan, Ata Abbasi, Ahmad Reza Dehpour

Differentiation-Dependent Doxorubicin Toxicity on H9c2 Cardiomyoblasts

Ana F. Branco, Susana F. Sampaio, Ana C. Moreira, Jon Holy, Kendall B. Wallace, Ines Baldeiras, Paulo J. Oliveira, Vilma A. Sardão

Cardiac Rhythm Disturbances Associated with Amlodipine Acute Intoxication

Carlos Henrique Miranda, Leudo Xavier, Flávio Fiorante, Gustavo Prata Misiara, Ellen Gonçalves Guimarães, Ana Marta Galli, Antônio Pazin-Filho, Marcos de Carvalho Borges